 |
Medicines
and Healthcare products Regulatory Agency Market Towers |
| Mr Charles Medawar |
General
enquiries Telephone 020 7273 0000 Fax 020 7273 0353 E-mail [email protected] www.mhra.gov.uk Direct
line: 020 7084 2664 Email: [email protected] 26 May 2006 |
| Dear Mr Medawar, RE: EFEXOR XI, (venlafaxine): PL 00011/0223-0224 & 00011/0199-0201 Advertisement in BMJ of 16 April 2005 Thank you for your letter of 10 May 2006 seeking copies of the corrective statement which resulted from your complaint concerning the advertisement for Efexor XL in the BMJ of 16 April 2005. Your letter indicates that you have been unable to obtain a copy of the corrective statement using the BMJ search facility. The statement was published in the BMJ and in other publications where the initial advertisement appeared. We have attached a copy of the corrective statement as it appeared in the BMJ on 12 November 2005. The statement has also been available on the MHRA website since that time, along with the report of the advertising complaint. With regard to your latter question, the BMJ report you identified, dated 16 April, referred to a previous case investigated by the MHRA. I have also attached a copy of the report of this case for your information. Yours sincerely, Dr Nageen Hashmi |